QLQX capsules, as adjunctive therapy to standard treatment, represent a cost-effective strategy for managing HFrEF in China, supporting their inclusion in clinical guidelines and reimbursement policies. Real-world studies are needed to validate these results further.
Abstract Over recent years, a number of initiatives have proposed standard reporting guidelines for functional genomics experiments. Associated with these are data models that m...
No AccessNov 2015Cancer in Low- and Middle-Income Countries: An Economic OverviewAuthors/Editors: Susan Horton and Cindy L. GauvreauSusan Horton and Cindy L. Gauvreauhttps://doi...
IntroductionWorldwide, more than 20 million patients undergo groin hernia repair annually. The many different approaches, treatment indications and a significant array of techni...
Social media, news, blog, policy document mentions